Delivery Order SPE2DB20D1100-SPE2DB25FE3K7
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of OJJAARA 150 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,863.71, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total ceiling value of $999,999,999.00 through December 2026. The contract contains no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, valued at $17,849.85 under a Firm Fixed Price contract type. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside delivery against the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,912.32 by the Defense Logistics Agency's Medical Supply Chain to supply OJJAARA 100 mg tablets in packages of 30 units. This firm fixed-price contract, awarded on August 28, 2025, with a completion date of September 19, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's...
- The Defense Logistics Agency awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) with an ultimate completion date of August 21, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The work will be performed at AmerisourceBergen's...
- This is a $17,849.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through July 28, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is a delivery order for OJJAARA 200 MG TABLET UU 30S. The contract is a firm fixed price agreement with a completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3K7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ojjaara 200 mg tablets in packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $17,849.85 with firm fixed pricing and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract history demonstrates consistent capability in fulfilling competitively awarded pharmaceutical delivery orders with diverse therapeutic products ranging from specialty medications to vaccines and medical devices across multiple customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 8/28/25 |